These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31632341)

  • 1. Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.
    Nissen MS; Blaabjerg M
    Front Neurol; 2019; 10():1056. PubMed ID: 31632341
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
    Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
    Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations of the anti-IgLON5 disease.
    Gaig C; Graus F; Compta Y; Högl B; Bataller L; Brüggemann N; Giordana C; Heidbreder A; Kotschet K; Lewerenz J; Macher S; Martí MJ; Montojo T; Pérez-Pérez J; Puertas I; Seitz C; Simabukuro M; Téllez N; Wandinger KP; Iranzo A; Ercilla G; Sabater L; Santamaría J; Dalmau J
    Neurology; 2017 May; 88(18):1736-1743. PubMed ID: 28381508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological criteria of anti-IgLON5-related tauopathy.
    Gelpi E; Höftberger R; Graus F; Ling H; Holton JL; Dawson T; Popovic M; Pretnar-Oblak J; Högl B; Schmutzhard E; Poewe W; Ricken G; Santamaria J; Dalmau J; Budka H; Revesz T; Kovacs GG
    Acta Neuropathol; 2016 Oct; 132(4):531-43. PubMed ID: 27358064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature.
    Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S
    J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgLON 5 Disease.
    Heidbreder A; Philipp K
    Curr Treat Options Neurol; 2018 Jun; 20(8):29. PubMed ID: 29936617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.
    Grüter T; Möllers FE; Tietz A; Dargvainiene J; Melzer N; Heidbreder A; Strippel C; Kraft A; Höftberger R; Schöberl F; Thaler FS; Wickel J; Chung HY; Seifert F; Tschernatsch M; Nagel M; Lewerenz J; Jarius S; Wildemann BC; de Azevedo L; Heidenreich F; Heusgen R; Hofstadt-van Oy U; Linsa A; Maaß JJ; Menge T; Ringelstein M; Pedrosa DJ; Schill J; Seifert-Held T; Seitz C; Tonner S; Urbanek C; Zittel S; Markewitz R; Korporal-Kuhnke M; Schmitter T; Finke C; Brüggemann N; Bien CI; Kleiter I; Gold R; Wandinger KP; Kuhlenbäumer G; Leypoldt F; Ayzenberg I;
    Brain; 2023 Feb; 146(2):600-611. PubMed ID: 35259208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Sleep Disorder in Anti-lgLON5 Disease.
    Gaig C; Iranzo A; Santamaria J; Graus F
    Curr Neurol Neurosci Rep; 2018 May; 18(7):41. PubMed ID: 29796717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epileptic Seizures and Right-Sided Hippocampal Swelling as Presenting Symptoms of Anti-IgLON5 Disease: A Case Report and Systematic Review of the Literature.
    Fu Y; Zou X; Liu L
    Front Neurol; 2022; 13():800298. PubMed ID: 35620785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-IgLON5 syndrome - what is our current understanding?].
    Wenninger S; Schoser B
    Fortschr Neurol Psychiatr; 2018 Sep; 86(9):559-565. PubMed ID: 30257262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IGLON5 disease: A new case without neuropathologic evidence of brainstem tauopathy.
    Erro ME; Sabater L; Martínez L; Herrera M; Ostolaza A; García de Gurtubay I; Tuñón T; Graus F; Gelpi E
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31826985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder.
    El Shazly J; Juenemann M; Gerriets T; Tschernatsch M
    Front Neurol; 2021; 12():632497. PubMed ID: 33633675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the sleep disorder of anti-IgLON5 disease.
    Gaig C; Iranzo A; Cajochen C; Vilaseca I; Embid C; Dalmau J; Graus F; Santamaria J
    Sleep; 2019 Sep; 42(9):. PubMed ID: 31198936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.
    Gaig C; Compta Y
    Curr Opin Neurol; 2019 Jun; 32(3):493-499. PubMed ID: 30694925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.
    Honorat JA; Komorowski L; Josephs KA; Fechner K; St Louis EK; Hinson SR; Lederer S; Kumar N; Gadoth A; Lennon VA; Pittock SJ; McKeon A
    Neurol Neuroimmunol Neuroinflamm; 2017 Sep; 4(5):e385. PubMed ID: 28761904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature.
    Grossauer A; Hussl A; Mahlknecht P; Peball M; Heidbreder A; Deisenhammer F; Djamshidian A; Seppi K; Heim B
    Mov Disord Clin Pract; 2023 Jan; 10(1):115-119. PubMed ID: 36698996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered ioflupane single-photon emission computed tomography in anti-IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature.
    González-Ávila C; Casado L; Muro García I; Villacieros-Álvarez J; Vivancos J; Quintas S
    Eur J Neurol; 2021 Apr; 28(4):1392-1395. PubMed ID: 33175431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IgLON5 disease: a novel topic beyond neuroimmunology.
    Zhang YH; Ni Y; Gao YN; Shen DD; He L; Yin D; Meng HY; Zhou QM; Hu J; Chen S
    Neural Regen Res; 2023 May; 18(5):1017-1022. PubMed ID: 36254983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report.
    Wang Y; Wu X; Lu B
    BMC Neurol; 2021 Mar; 21(1):120. PubMed ID: 33731000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome.
    Sabater L; Planagumà J; Dalmau J; Graus F
    J Neuroinflammation; 2016 Sep; 13(1):226. PubMed ID: 27586161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.